For patients with pseudomonal risk factors, therapy can be with a two-drug regimen, using an anti-pseudomonal β-lactam (imipenem, meropenem, piperacillin-tazobactam, cefepime) plus ciprofloxacin (the most active antipseudomonal quinolone) or levofloxacin (750 mg daily). Alternatively, a three-...